These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 13507764)

  • 1. Urinary excretion of some products of tryptophan metabolism in schizophrenic patients.
    CAFRUNY EJ; DOMINO EF
    AMA Arch Neurol Psychiatry; 1958 Mar; 79(3):336-40. PubMed ID: 13507764
    [No Abstract]   [Full Text] [Related]  

  • 2. Urinary excretion of tryptophan metabolites by schizophrenic individuals.
    BROWN FC; WHITE JB; KENNEDY JK
    Am J Psychiatry; 1960 Jul; 117():63-5. PubMed ID: 13804925
    [No Abstract]   [Full Text] [Related]  

  • 3. Excretion of catecholamines and tryptophan derivatives in schizophrenia.
    Mileikovskii YA
    Neurosci Behav Physiol; 1979; 9(4):325-8. PubMed ID: 158714
    [No Abstract]   [Full Text] [Related]  

  • 4. Detection of psychotomimetic N,N-dimethylated indoleamines in the urine of four schizophrenic patients.
    Tanimukai H; Ginther R; Spaide J; Bueno JR; Himwich HE
    Br J Psychiatry; 1970 Oct; 117(539):421-30. PubMed ID: 5312352
    [No Abstract]   [Full Text] [Related]  

  • 5. Investigations on the tryptophan content of urines from schizophrenics and other psychotic patients.
    EDELSTEIN EL; KRASSILOWSKY D
    J Nerv Ment Dis; 1959 May; 128(5):459-61. PubMed ID: 13665369
    [No Abstract]   [Full Text] [Related]  

  • 6. Experimental data to the pathogenesis of cryptopyrrole excretion in schizophrenia, I.
    Huszák I; Durkó I; Karsai K
    Acta Physiol Acad Sci Hung; 1972; 42(1):79-86. PubMed ID: 4664398
    [No Abstract]   [Full Text] [Related]  

  • 7. URINARY TRYPTAMINE AND INDOLE-3-ACETIC ACID EXCRETION BY SCHIZOPHRENIC PATIENTS: USE OF THE TRYPTAMINE/INDOLE ACETIC ACID RATIO AS AN INDEX OF MONOAMINE OXIDASE INHIBITION.
    LABROSSE EH; KOPIN IJ; FELIX WR; WESTLAKE RJ
    J Psychiatr Res; 1964 Oct; 2():185-97. PubMed ID: 14242376
    [No Abstract]   [Full Text] [Related]  

  • 8. Decreased tryptophan excretion by depressive patients.
    Wood K; Harwood J; Swade C; Coppen A
    Clin Chim Acta; 1978 Aug; 88(1):57-61. PubMed ID: 679495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The urinary excretion of tryptophan by human subjects on controlled diets varying in levels and sources of protein.
    FRAZIER EI
    J Nutr; 1954 May; 53(1):115-27. PubMed ID: 13163761
    [No Abstract]   [Full Text] [Related]  

  • 10. EXCRETION OF CATECHOLAMINES AND EXACERBATION OF SYMPTOMS IN SCHIZOPHRENIC PATIENTS.
    PSCHEIDT GR; BERLET HH; BULL C; SPAIDE J; HIMWICH HE
    J Psychiatr Res; 1964 Oct; 2():163-8. PubMed ID: 14242374
    [No Abstract]   [Full Text] [Related]  

  • 11. Urinary excretion of phenolic acids by normal and schizophrenic male patients.
    MANN JD; LABROSSE EH
    AMA Arch Gen Psychiatry; 1959 Nov; 1():547-51. PubMed ID: 14420663
    [No Abstract]   [Full Text] [Related]  

  • 12. The urinary excretion of adrenaline and noradrenaline by schizophrenic patients during reserpine treatment.
    CARLSSON A; RASMUSSEN EB; KRIST JANSEN P
    J Neurochem; 1959 Oct; 4():318-20. PubMed ID: 13807780
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of schistosomiasis on the urinary excretion of tryptophan metabolites.
    TROUT GE; GILLMAN J; PRATES MD
    S Afr J Med Sci; 1960 Dec; 25():150-1. PubMed ID: 13778217
    [No Abstract]   [Full Text] [Related]  

  • 14. EFFECTS OF REDUCTION OF TRYPTOPHAN AND METHIONINE INTAKE ON URINARY INDOLE COMPOUNDS AND SCHIZOPHRENIC BEHAVIOR.
    BERLET HH; SPAIDE J; KOHL H; BULL C; HIMWICH HE
    J Nerv Ment Dis; 1965 Apr; 140():297-304. PubMed ID: 14330437
    [No Abstract]   [Full Text] [Related]  

  • 15. Changes in the urinary excretion of the metabolites of the tryptophan-niacin pathway during pregnancy in Japanese women and rats.
    Ftukijwatari T; Murakami M; Ohta M; Kimura N; Jin-No Y; Sasaki R; Shibata K
    J Nutr Sci Vitaminol (Tokyo); 2004 Dec; 50(6):392-8. PubMed ID: 15895513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schizophrenic behavior and urinary tryptophan metabolites associated with cysteine given with and without a monoamine oxidase inhibitor (tranylcypromine).
    Spaide J; Tanimukai H; Ginther R; Bueno J; Himwich HE
    Life Sci; 1967 Mar; 6(5):551-60. PubMed ID: 4226702
    [No Abstract]   [Full Text] [Related]  

  • 17. The urinary excretion of tryptophan and tryptophan metabolites in the chronic ethanol-fed rat.
    Bonner AB; Brien S; Preedy VR
    J Pharm Pharmacol; 1993 Feb; 45(2):81-5. PubMed ID: 7680711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some aspects of tryptophan metabolism in human subjects. II. Urinary tryptophan metabolites on a low-niacin diet.
    BROWN RR; VIVIAN VM; REYNOLDS MS; PRICE JM
    J Nutr; 1958 Dec; 66(4):599-606. PubMed ID: 13621284
    [No Abstract]   [Full Text] [Related]  

  • 19. [Urinary excretion of blastomogenic tryptophan metabolites in tubazide- and phthivazid-treated patients].
    Martynenko AG; Kartasheva LA; Aberun DE
    Vopr Onkol; 1981; 27(7):43-7. PubMed ID: 7196643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Urinary excretion of 5-HIAA in normal Chinese and schizophrenic subjects. III. T.L.T. in presence of tranquilizers for chronic schizophrenics].
    LEE SJ
    Taehan Naekwa Hakhoe Chapchi; 1962 Jan; 5():41-6. PubMed ID: 14463565
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.